uniQure (QURE) Operating Margin Growth (1y) (2017 - 2026)
uniQure (QURE) Operating Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
uniQure |
2.88 Bn |
2.88 Bn |
3.34 Mn |
122,641.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
122,641.00 |
| Dec 31, 2025 |
239,265.00 |
| Sep 30, 2025 |
38,003.00 |
| Jun 30, 2025 |
-43,806.00 |
| Mar 31, 2025 |
-187,085.00 |
| Dec 31, 2024 |
-300,111.00 |
| Sep 30, 2024 |
406,028.00 |
| Jun 30, 2024 |
229,123.00 |
| Mar 31, 2024 |
75,380.00 |
| Dec 31, 2023 |
209,756.00 |
| Sep 30, 2023 |
-171,174.00 |
| Jun 30, 2023 |
859,309.00 |
| Mar 31, 2023 |
162,496.00 |
| Dec 31, 2022 |
41,641.00 |
| Sep 30, 2022 |
-184,508.00 |
| Jun 30, 2022 |
-1.14 Mn |
| Mar 31, 2022 |
677,465.00 |
| Dec 31, 2021 |
-36,637.00 |
| Sep 30, 2021 |
22,442.00 |
| Jun 30, 2021 |
257,492.00 |
